Fleury Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Jeane Tsutsui

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	4.5yrs
Promedio de permanencia en la Junta Directiva	5.4yrs

Actualizaciones recientes de la dirección

Recent updates

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 28

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Feb 15

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Feb 02

Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Jan 03

Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Dec 28

Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Dec 12

Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Nov 29

Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Aug 30

Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Aug 18

Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Aug 03

Could The Fleury S.A. (BVMF:FLRY3) Ownership Structure Tell Us Something Useful?

Jul 22

Is Now The Time To Look At Buying Fleury S.A. (BVMF:FLRY3)?

Jul 10

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Jun 25

CEO

Jeane Tsutsui

no data

Permanencia

Ms. Jeane Mike Tsutsui serves as Chief Executive Officer and President of Executive Board at Fleury S.A. and served as its Brands Officer since 2019. She is also an Advisor at Kortex Ventures. Ms. Tsutsui...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Jeane Tsutsui	CEO & President of Executive Board	no data	sin datos	sin datos
Jose de Almeida Filippo	CFO, Investor Relations Officer & Member of Executive Board	2.5yrs	sin datos	sin datos
Claudio Prado	Executive Director of New Links & Member of Executive Board	7.8yrs	sin datos	sin datos
Edgar Rizzatti	Medical	6.4yrs	sin datos	sin datos
Roberto Meirelles	L2L & Operations Support Officer and Member of Executive Board	less than a year	sin datos	sin datos
Fernando Camargo	Secretary	no data	sin datos	sin datos

4.5yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de FLRY3 se considera experimentado (4.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Rui de Barros Maciel	External Director	5.4yrs	sin datos	sin datos
Samuel dos Santos	External Director	no data	sin datos	sin datos
Ivan Gontijo	Director	no data	sin datos	sin datos
Manoel Peres	Alternate Director	no data	sin datos	sin datos
Marcio Mendes	Chairman	5.4yrs	sin datos	0.73% R$ 57.1m
Fernando Alberto	Vice-Chairman	24.4yrs	sin datos	0.65% R$ 50.8m
Octavio de Lazari	Alternate Director	6.7yrs	sin datos	sin datos
Luiz Carlos Cappi	External Director	5.6yrs	sin datos	sin datos
Joao Goncalves Teixeira	Independent Director	2.5yrs	sin datos	sin datos
Regina Pardini	Independent Director	1.4yrs	sin datos	sin datos
Victor Pardini	Independent Director	1.4yrs	sin datos	sin datos
Marcio de Paula Ricardo	Independent Director	no data	sin datos	sin datos

5.4yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de FLRY3 se considera experimentada (5.3 años de antigüedad promedio).

Fleury Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Less than half of directors are independent

Less than half of directors are independent

High number of new directors

Recent updates

First quarter 2024 earnings released

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Upcoming dividend of R$0.15 per share

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 22% undervalued after recent price drop

Fleury S.A. to Report Q3, 2024 Results on Nov 07, 2024

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Consensus EPS estimates increase by 10%, revenue downgraded

Third quarter 2023 earnings: Revenues in line with analyst expectations

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Second quarter 2023 earnings: Revenues in line with analyst expectations

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

New major risk - Shareholder dilution

Fleury S.A. to Report Q3, 2023 Results on Nov 09, 2023

First quarter 2023 earnings: Revenues exceed analyst expectations

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Less than half of directors are independent

Consensus forecasts updated

Consensus forecasts updated

Third quarter 2022 earnings: Revenues exceed analyst expectations

Fleury S.A. (BOVESPA:FLRY3) completed the acquisition of Methodos laboratory in Minas Gerais.

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Second quarter 2022 earnings: Revenues exceed analyst expectations

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Investor sentiment improved over the past week

Less than half of directors are independent

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

First quarter 2022 earnings: Revenues exceed analyst expectations

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Now 24% undervalued after recent price drop

Consensus forecasts updated

Price target decreased to R$20.75

Now 22% undervalued after recent price drop

Fleury S.A. to Report Fiscal Year 2021 Results on Mar 17, 2022

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Now 20% undervalued after recent price drop

High number of new directors

Price target decreased to R$23.18

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Price target decreased to R$26.38

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Second quarter 2021 earnings released

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Consensus EPS estimates increase to R$1.19

First quarter 2021 earnings released

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Analysts update estimates

New 90-day low: R$25.63

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Revenue and earnings beat expectations

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Full year 2020 earnings released

Fleury S.A. to Report Q4, 2020 Results on Feb 25, 2021

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Analysts increase EPS estimates to R$0.61

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

New 90-day low: R$25.82